Clinical Trial Update: Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Progevera 10 mg to Orgalutran in ovarian stimulation of oocyte donors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Orgalutran (ganirelix)
• Progevera 10 mg

Snippet

Sponsor: Fundació Privada Eugin | Conditions: Infertility | Phase 4 | Status: COMPLETED